KathrynMarieCappellMDPHD

Summary

• I began my medical training at UNC-Chapel Hill where I completed a combined Medical Science Training Program (MSTP) MD/PhD degree. My research for my PhD was in the area of cancer pharmacology identifying modulators of chemosensitivity to paclitaxel. The time I spent performing research generated two first author publications, multiple middle author publications, and gave me experience in generating and testing research hypotheses. During my PhD training, I developed an interest in the development of oncology therapeutics and I therefore completed my medical training with the goal of specializing in hematology and oncology. I completed my residency training in internal medicine at Stanford University followed by a fellowship in blood and marrow transplantation at Stanford University. I then completed my training in hematology/oncology at the National Cancer Institute (NCI). At the NCI, my research has focused on the development of chimeric antigen receptor T cells (CAR T) cells for lymphoma. My recent work in this area was highlighted at the American Society of Clinical Oncology (ASCO) 2020 conference in a poster discussion session. I have also been recognized for my strong work at the NCI by being named associate chief fellow in 2019-2020, earning the Herb Kotz Exemplary Oncologist award, and an ASCO endowed merit award in 2020.